Luque, Melani; Sanz Álvarez, Marta; Santamaría, Andrea; Zazo, Sandra; Cristóbal, Ion; Fuente, Lorena de la; Mínguez, Pablo; Eroles, Pilar; Rovira Guerín, Ana; Albanell Mestres, Joan; Madoz-Gúrpide, Juan; Rojo, Federico
(MDPI, 2021)
The combination of trastuzumab plus pertuzumab plus docetaxel as a first-line therapy in patients with HER2-positive metastatic breast cancer has provided significant clinical benefits compared to trastuzumab plus docetaxel ...